APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atezolizumab

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Atezolizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025176 pages

Choose your research edition.

Industry ResearchAtezolizumab Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Atezolizumab Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Atezolizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atezolizumab Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Atezolizumab Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Atezolizumab market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Atezolizumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Atezolizumab include Genentech (Roche). among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Atezolizumab market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Atezolizumab and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atezolizumab sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atezolizumab market size, projected growth trends, production technologies, key applications, and end-use industries.

Atezolizumab Segment by Company

Genentech (Roche)

Atezolizumab Segment by Type

Use: Single Drug

Use: ChemOthersapy Combination

Atezolizumab Segment by Application

Advanced Triple-negative Breast Cancer

Head and Neck Cancer

Renal Cell Carcinoma

Urothelial Carcinoma

Hepatocellular Carcinoma (HCC)

Lung Cancer

Bladder Cancer

Others

Atezolizumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atezolizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atezolizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atezolizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atezolizumab market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atezolizumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Atezolizumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Atezolizumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Atezolizumab Industry Trends Table 2. Atezolizumab Industry Drivers Table 3. Atezolizumab Industry Opportunities and Challenges Table 4. Atezolizumab Industry Restraints Table 5. Global Atezolizumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Atezolizumab Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Atezolizumab Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Atezolizumab Sales Market Share by Manufacturers Table 9. Global Atezolizumab Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Atezolizumab Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Atezolizumab Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Atezolizumab Manufacturers, Product Type & Application Table 13. Global Atezolizumab Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Atezolizumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Use: Single Drug Table 17. Major Manufacturers of Use: ChemOthersapy Combination Table 18. Global Atezolizumab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Atezolizumab Sales by Type (2021-2026) & (k units) Table 20. Global Atezolizumab Sales by Type (2027-2032) & (k units) Table 21. Global Atezolizumab Sales Market Share by Type (2021-2026) Table 22. Global Atezolizumab Sales Market Share by Type (2027-2032) Table 23. Global Atezolizumab Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Atezolizumab Revenue by Type (2021-2026) & (k units) Table 25. Global Atezolizumab Revenue by Type (2027-2032) & (k units) Table 26. Global Atezolizumab Revenue Market Share by Type (2021-2026) Table 27. Global Atezolizumab Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Advanced Triple-negative Breast Cancer Table 29. Major Manufacturers of Head and Neck Cancer Table 30. Major Manufacturers of Renal Cell Carcinoma Table 31. Major Manufacturers of Urothelial Carcinoma Table 32. Major Manufacturers of Hepatocellular Carcinoma (HCC) Table 33. Major Manufacturers of Lung Cancer Table 34. Major Manufacturers of Bladder Cancer Table 35. Major Manufacturers of Others Table 36. Global Atezolizumab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Atezolizumab Sales by Application (2021-2026) & (k units) Table 38. Global Atezolizumab Sales by Application (2027-2032) & (k units) Table 39. Global Atezolizumab Sales Market Share by Application (2021-2026) Table 40. Global Atezolizumab Sales Market Share by Application (2027-2032) Table 41. Global Atezolizumab Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Atezolizumab Revenue by Application (2021-2026) & (k units) Table 43. Global Atezolizumab Revenue by Application (2027-2032) & (k units) Table 44. Global Atezolizumab Revenue Market Share by Application (2021-2026) Table 45. Global Atezolizumab Revenue Market Share by Application (2027-2032) Table 46. Global Atezolizumab Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Atezolizumab Sales by Region (2021-2026) & (k units) Table 48. Global Atezolizumab Sales Market Share by Region (2021-2026) Table 49. Global Atezolizumab Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Atezolizumab Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Atezolizumab Sales by Country (2021-2026) & (k units) Table 53. North America Atezolizumab Sales by Country (2027-2032) & (k units) Table 54. Europe Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Atezolizumab Sales by Country (2021-2026) & (k units) Table 56. Europe Atezolizumab Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Atezolizumab Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Atezolizumab Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Atezolizumab Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Atezolizumab Sales by Country (2027-2032) & (k units) Table 63. Global Atezolizumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Atezolizumab Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Atezolizumab Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Atezolizumab Revenue Market Share by Region (2021-2026) Table 67. Global Atezolizumab Revenue Market Share by Region (2027-2032) Table 68. Genentech (Roche) Company Information Table 69. Genentech (Roche) Business Overview Table 70. Genentech (Roche) Atezolizumab Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Genentech (Roche) Atezolizumab Product Portfolio Table 72. Genentech (Roche) Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Atezolizumab Distributors List Table 76. Atezolizumab Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Atezolizumab Product Image Figure 2. Global Atezolizumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atezolizumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Atezolizumab Sales (2021-2032) & (k units) Figure 5. Global Atezolizumab Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Atezolizumab Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Use: Single Drug Image Figure 9. Use: ChemOthersapy Combination Image Figure 10. Global Atezolizumab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Atezolizumab Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Atezolizumab Sales Market Share by Type (2021-2032) Figure 13. Global Atezolizumab Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Atezolizumab Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Atezolizumab Revenue Market Share by Type (2021-2032) Figure 16. Advanced Triple-negative Breast Cancer Image Figure 17. Head and Neck Cancer Image Figure 18. Renal Cell Carcinoma Image Figure 19. Urothelial Carcinoma Image Figure 20. Hepatocellular Carcinoma (HCC) Image Figure 21. Lung Cancer Image Figure 22. Bladder Cancer Image Figure 23. Others Image Figure 24. Global Atezolizumab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Atezolizumab Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Atezolizumab Sales Market Share by Application (2021-2032) Figure 27. Global Atezolizumab Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Atezolizumab Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Atezolizumab Revenue Market Share by Application (2021-2032) Figure 30. North America Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Atezolizumab Sales Market Share by Country (2021-2032) Figure 32. U.S. Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Atezolizumab Sales Market Share by Country (2021-2032) Figure 37. Germany Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Atezolizumab Sales Market Share by Country (2021-2032) Figure 44. China Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Atezolizumab Sales Market Share by Country (2021-2032) Figure 52. Brazil Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Atezolizumab Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Atezolizumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Atezolizumab Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Atezolizumab Revenue (2021-2032) & (US$ Million) Figure 63. North America Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Atezolizumab Revenue (2021-2032) & (US$ Million) Figure 65. Europe Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Atezolizumab Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Atezolizumab Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Atezolizumab Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Atezolizumab Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Use: Single Drug
  • Use: ChemOthersapy Combination
Applications
  • Advanced Triple-negative Breast Cancer
  • Head and Neck Cancer
  • Renal Cell Carcinoma
  • Urothelial Carcinoma
  • Hepatocellular Carcinoma (HCC)
  • Lung Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Genentech (Roche)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Atezolizumab Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Atezolizumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Atezolizumab Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Atezolizumab Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Atezolizumab Market Dynamics
  1. 2.1 Atezolizumab Industry Trends
  2. 2.2 Atezolizumab Industry Drivers
  3. 2.3 Atezolizumab Industry Opportunities and Challenges
  4. 2.4 Atezolizumab Industry Restraints
3 Atezolizumab Market by Manufacturers
  1. 3.1 Global Atezolizumab Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Atezolizumab Sales by Manufacturers (2021-2026)
  3. 3.3 Global Atezolizumab Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Atezolizumab Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atezolizumab Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Atezolizumab Manufacturers, Product Type & Application
  7. 3.7 Global Atezolizumab Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atezolizumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atezolizumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atezolizumab Tier 1, Tier 2, and Tier 3
4 Atezolizumab Market by Type
  1. 4.1 Atezolizumab Type Introduction
  2. 4.1.1 Use: Single Drug
  3. 4.1.2 Use: ChemOthersapy Combination
  4. 4.2 Global Atezolizumab Sales by Type
  5. 4.2.1 Global Atezolizumab Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Atezolizumab Sales by Type (2021-2032)
  7. 4.2.3 Global Atezolizumab Sales Market Share by Type (2021-2032)
  8. 4.3 Global Atezolizumab Revenue by Type
  9. 4.3.1 Global Atezolizumab Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Atezolizumab Revenue by Type (2021-2032)
  11. 4.3.3 Global Atezolizumab Revenue Market Share by Type (2021-2032)
5 Atezolizumab Market by Application
  1. 5.1 Atezolizumab Application Introduction
  2. 5.1.1 Advanced Triple-negative Breast Cancer
  3. 5.1.2 Head and Neck Cancer
  4. 5.1.3 Renal Cell Carcinoma
  5. 5.1.4 Urothelial Carcinoma
  6. 5.1.5 Hepatocellular Carcinoma (HCC)
  7. 5.1.6 Lung Cancer
  8. 5.1.7 Bladder Cancer
  9. 5.1.8 Others
  10. 5.2 Global Atezolizumab Sales by Application
  11. 5.2.1 Global Atezolizumab Sales by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Atezolizumab Sales by Application (2021-2032)
  13. 5.2.3 Global Atezolizumab Sales Market Share by Application (2021-2032)
  14. 5.3 Global Atezolizumab Revenue by Application
  15. 5.3.1 Global Atezolizumab Revenue by Application (2021 VS 2025 VS 2032)
  16. 5.3.2 Global Atezolizumab Revenue by Application (2021-2032)
  17. 5.3.3 Global Atezolizumab Revenue Market Share by Application (2021-2032)
6 Global Atezolizumab Sales by Region
  1. 6.1 Global Atezolizumab Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atezolizumab Sales by Region (2021-2032)
  3. 6.2.1 Global Atezolizumab Sales by Region (2021-2026)
  4. 6.2.2 Global Atezolizumab Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Atezolizumab Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Atezolizumab Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Atezolizumab Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Atezolizumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Atezolizumab Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Atezolizumab Revenue by Region
  1. 7.1 Global Atezolizumab Revenue by Region
  2. 7.1.1 Global Atezolizumab Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Atezolizumab Revenue by Region (2021-2026)
  4. 7.1.3 Global Atezolizumab Revenue by Region (2027-2032)
  5. 7.1.4 Global Atezolizumab Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Atezolizumab Revenue (2021-2032)
  8. 7.2.2 North America Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Atezolizumab Revenue (2021-2032)
  11. 7.3.2 Europe Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Atezolizumab Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Atezolizumab Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Atezolizumab Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Genentech (Roche)
  2. 8.1.1 Genentech (Roche) Company Information
  3. 8.1.2 Genentech (Roche) Business Overview
  4. 8.1.3 Genentech (Roche) Atezolizumab Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genentech (Roche) Atezolizumab Product Portfolio
  6. 8.1.5 Genentech (Roche) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atezolizumab Value Chain Analysis
  2. 9.1.1 Atezolizumab Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atezolizumab Production Mode & Process
  6. 9.2 Atezolizumab Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atezolizumab Distributors
  9. 9.2.3 Atezolizumab Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst